Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)
CompletedNCT00249834
Merck KGaA, Darmstadt, GermanyInfertility
Start: 2004-09-22End: 2006-01-16Updated: 2018-03-30